Genetic Analysis AS (NGM:GEAN)
Sweden flag Sweden · Delayed Price · Currency is SEK · Price in NOK
1.280
+0.060 (4.92%)
At close: May 13, 2025
96.92%
Market Cap 59.36M
Revenue (ttm) 20.15M
Net Income (ttm) -14.39M
Shares Out 49.38M
EPS (ttm) -0.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 111,358
Average Volume 143,918
Open 1.260
Previous Close 1.220
Day's Range 1.260 - 1.490
52-Week Range n/a
Beta 2.59
RSI 54.80
Earnings Date May 27, 2025

About Genetic Analysis AS

Genetic Analysis AS, a science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally. It offers GA-map, a platform for the analysis of the human gut microbiota; GA-map Dysbiosis Test that detects and characterizes dysbiosis; and GA-map Analyzer, a cloud-based software solution. The company also provides GA-map Discovery, a tool to search biomarkers and validate research findings or transfer the findings to a ready-to-use routine testing platform; GA-map Sample Colle... [Read more]

Sector Healthcare
Founded 2008
Employees 16
Stock Exchange Nordic Growth Market
Ticker Symbol GEAN
Full Company Profile

Financial Performance

In 2024, Genetic Analysis AS's revenue was 20.68 million, a decrease of -10.71% compared to the previous year's 23.16 million. Losses were -14.77 million, -37.99% less than in 2023.

Financial numbers in NOK Financial Statements

News

There is no news available yet.